[ Price : $8.95]
Federal Register Notice: FDA determines that 13 ANDAs were not withdrawn from sale for reasons of safety or effectiveness.[ Price : $8.95]
Federal Register Notice: FDA announces a stay of portions of its final guidance: Investigational New Drug Applications Determinin...[ Price : $8.95]
Federal Register Notice: FDA plans a public workshop 12/2: Clinical Trials Assessing Safety and Efficacy in Diverse Populations....[ Price : $8.95]
Federal Register Notice: FDA reopens the comment period for the draft guidance on minimal manipulation of human cells, tissues, an...[ Price : $8.95]
Federal Register Notice: FDA will hold a public hearing 4/13/16 on four recent draft guidance on the regulation of human cells, ti...[ Price : $8.95]
Federal Register Notice: FDA reopens the comment period on a draft guidance: Same Surgical Procedure Exception: Questions and Answ...[ Price : $8.95]
FDA posts a draft guidance on Progesterone Bioequivalence Recommendations that provides the current agency thinking on studies tha...[ Price : $8.95]
Quest Medical recalls its Myocardial Protection System Delivery Sets due to the potential to have intermittent seal failure during...